Unusual global outbreak of monkeypox:what should we do?

被引：0
|
作者：
Miaojin Zhu [1 ]
Jia Ji [1 ]
Danrong Shi [1 ]
Xiangyun Lu [1 ]
Baohong Wang [1 ,2 ]
Nanping Wu [1 ,2 ]
Jie Wu [1 ,2 ]
Hangping Yao [1 ,2 ]
Lanjuan Li [1 ,2 ]
机构：
[1] State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,School of Med
[2] Jinan Microecological Biomedicine Shandong
来源：
Frontiers of Medicine. | 2022年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recently,monkeypox has become a global concern amid the ongoing COVID-19 pandemic.Monkeypox is an acute rash zoonosis caused by the monkeypox virus,which was previously concentrated in Africa.The re-emergence of this pathogen seems unusual on account of outbreaks in multiple nonendemic countries and the incline to spread from person to person.We need to revisit this virus to prevent the epidemic from getting worse.In this review,we comprehensively summarize studies on monkeypox,including its epidemiology,biological characteristics,pathogenesis,and clinical characteristics,as well as therapeutics and vaccines,highlighting its unusual outbreak attributed to the transformation of transmission.We also analyze the present situation and put forward countermeasures from both clinical and scientific research to address it.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Investigating the monkeypox outbreak Here's what we know, and what we need to know
    Dye, Christopher
    Kraemer, Moritz U. G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [22] The Current Multicountry Monkeypox Outbreak: What Water Professionals Should Know
    Maal-Bared, Rasha
    Gerba, Charles
    Bibby, Kyle
    Munakata, Naoko
    Mehrotra, Anna S.
    Brisolara, Kari Fitzmorris
    Haas, Charles
    Gary, Lee
    Nayak, Bina
    Swift, Jay
    Sherchan, Samendra
    Casson, Leonard
    Olabode, Lola
    Rubin, Albert
    Reimers, Robert
    Sobsey, Mark
    [J]. ACS ES&T WATER, 2022, 2 (10): : 1628 - 1638
  • [23] Atrial fibrillation:: What can we do, what should we do, and what must we do?
    Gjesdal, K
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2005, 39 (06) : 324 - 326
  • [24] Neurocognitive enhancement: what can we do and what should we do?
    Farah, MJ
    Illes, J
    Cook-Deegan, R
    Gardner, H
    Kandel, E
    King, P
    Parens, E
    Sahakian, B
    Wolpe, PR
    [J]. NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) : 421 - 425
  • [25] What We Know About Monkeypox and What We Need to Do to Protect Ourselves!
    Nalca, Ayseguel
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 218 - 220
  • [26] Bifurcation Disease What Do We Know, What Should We Do?
    Latib, Azeem
    Colombo, Antonio
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (03) : 218 - 226
  • [27] Cannabis and psychosis: what do we know and what should we do?
    Colizzi, Marco
    Murray, Robin
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2018, 212 (04) : 195 - 196
  • [28] Neighborhoods and Health: What Do We Know? What Should We Do?
    Roux, Ana V. Diez
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (03) : 430 - 431
  • [29] Prevention and Pharmacovigilance What Should We Do, What Can We Do?
    Edwards, I. Ralph
    [J]. DRUG SAFETY, 2012, 35 (02) : 87 - 90
  • [30] Neurocognitive enhancement: what can we do and what should we do?
    Martha J. Farah
    Judy Illes
    Robert Cook-Deegan
    Howard Gardner
    Eric Kandel
    Patricia King
    Eric Parens
    Barbara Sahakian
    Paul Root Wolpe
    [J]. Nature Reviews Neuroscience, 2004, 5 : 421 - 425
12345